Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression. | Eur Urol;86(2): 184-185, 2024 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression.

St-Laurent, Marie-Pier; Black, Peter C.

Affiliation

St-Laurent MP; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address: mst-laurent@prostatecentre.com.
Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Eur Urol ; 86(2): 184-185, 2024 Aug.

Article in En | MEDLINE | ID: mdl-38614823

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Limits: Animals Language: En Journal: Eur Urol Year: 2024 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Limits: Animals Language: En Journal: Eur Urol Year: 2024 Document type: Article Country of publication: